Shopping Cart
- Remove All
- Your shopping cart is currently empty
EBI-2511 is a highly potent, orally active inhibitor of EZH2, with an IC50 of 6 nM in Pfeffiera cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $60 | In Stock | |
5 mg | $147 | In Stock | |
10 mg | $228 | In Stock | |
25 mg | $478 | In Stock | |
50 mg | $690 | In Stock | |
100 mg | $992 | In Stock |
Description | EBI-2511 is a highly potent, orally active inhibitor of EZH2, with an IC50 of 6 nM in Pfeffiera cell lines. |
Targets&IC50 | EZH2:6 nM (in cell) |
In vitro | EBI-2511 obviously decreases cellular H3K27me3 levels in a dose-dependent manner (an approximate IC50: 8 nM) and it is 3-fold more potent than EPZ-6438. In addition to Pfeffier cell line, EBI-2511 was shown active against WSU-DLCL2 ( IC50: 55 nM) [1]. |
In vivo | EBI-2511 demonstrates dose-dependent tumor growth inhibition, with tumor size reductions of 28% (10mg/kg), 83% (30mg/kg), and 97% (100mg/kg). No significant changes in body weights are observed across all treatment groups. At the same dosage, EBI-2511 shows superior anti-tumor efficacy compared to EPZ-6438 (P<0.01) [1]. |
Molecular Weight | 576.77 |
Formula | C34H48N4O4 |
Cas No. | 2098546-05-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 5 mg/mL (8.67 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.